ArticleCancers2025

Model Predicting Survival in Intermediate-Stage HCC Patients Reclassified for TACE Based on the 2022 BCLC Criteria.

Jihoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.